The Stop TB Partnership applauds the Presidential TB Bill that crowns Indonesia’s commitment to ending the TB epidemic by 2030.

The Stop TB Partnership’s Global Drug Facility (GDF) announced the inclusion in its catalog, for the first time ever, of two ultra-portable digital X-ray systems and two software packages for the computer-aided detection of TB based on artificial intelligence. These important digital tools to combat TB will be made available at a reduced cost to all TB programs in low- and middle-income countries.

The Stop TB Partnership’s TB REACH announced approval of 11 new Wave 9 projects selected for funding to address inequities in drug-resistant TB in partnership with the United States Agency for International Development (USAID) Global Accelerator to End TB for a total of US$6.14 million.

Progress in COVID-19 vaccine development shows the value of investing in vaccines, yet TB vaccine research received only 20% of needed funding in 2019.

16 June 2021, Geneva, Switzerland - The Stop TB Partnership and Bamboo Capital Partners, an impact investing platform, signed a partnership agreement to support small- and medium-enterprises and start-ups, particularly from TB affected countries, developing impactful health technologies for TB, COVID-19, and TB co-morbidities.

Celebrating TB heroes during the COVID-19 pandemic.

The 2021 Political Declaration on HIV and AIDS, adopted by world leaders, commits to end HIV/AIDS and TB by 2030 and reverse the progress lost due to the COVID-19 pandemic.

The Stop TB Partnership and USAID launch a new report assessing the governance of National TB Programmes in 22 countries which together account for over 70% of the global TB burden.

The Stop TB Partnership launches the first of two online consultations to inform the development of the new Global Plan to End TB for the period 2023 to 2030.

On this year’s International Nurses Day, the Stop TB Partnership is humbled to pay tribute to nurses and highlight the crucial work they play every single day to support people suffering and in need of diagnosis, treatment, and care due to tuberculosis (TB), COVID-19, and many other diseases.